Above-Guidance Revenue and EPS
Fourth quarter revenue came in at $445.6 million, exceeding guidance despite a 4% negative foreign currency impact. Adjusted earnings per share surpassed guidance at $0.38.
Significant Debt Reduction
Nu Skin reduced its debt by $110 million funded entirely through cash operations, and further reduced debt by $115 million with proceeds from the sale of Mavely.
Strong Performance in Developing Markets
Encouraging growth in Latin America and Southeast Asia with a 28% year-on-year growth in the RISE segment.
Successful Strategic Transaction
Sold Mavely for $250 million, generating a five times return on investment and strengthening the balance sheet.
Operational Efficiency Improvements
Adjusted operating margin for Q4 was 7.7%, an improvement of 130 basis points from the prior year.